Few patients undergoing implantation of the WATCHMAN left atrial appendage occlusion (LAAO) device receive post-discharge treatment consistent with the protocols studied in clinical trials, according to a study presented Nov. 13 during AHA 2020. The study, which used data from ACC’s LAAO Registry, looked at real-word patterns of post-procedural …
Understand and strategically utilize the new program signaling feature for the 2026 Cardiovascular Fellowship MyERAS ® application season. Join ACC’s Program Directors and Graduate Medical…
Abstracts are now open! Want to take your abstract a step further: Turn your Quality Summit abstract into a published case report! Join Mary Norine…
A fixed-dose combination therapy of obicetrapib plus ezetimibe was found to significantly reduce LDL-C in patients with preexisting or at high risk for developing atherosclerotic…
Nominations are due by June 23, 2023. Submit your nominations today!
Call For Applications | US Vice Chair, ACC Latin America
The use of IVUS to assess the coronary ostia at high risk for coronary artery obstruction (CAO) after TAVR is feasible, safe and potentially lifesaving,…
A previously healthy 13-year-old girl presents to the emergency department (ED) after an episode of syncope. Her older sister reported that, after sitting up in…
The Wael Al Mahmeed Dedication to Young Leaders program was created to train and support the next generation of cardiovascular leaders internationally.
Use of direct oral anticoagulants (DOACs) as opposed to warfarin after TAVR exhibited a lower risk of bleeding requiring hospitalization, all-cause mortality and stroke at…
